Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Cecile Krejsa"'
Publikováno v:
HemaSphere, Vol 7, p e44843f0 (2023)
Externí odkaz:
https://doaj.org/article/885a82105f6a430d941ebfebab56d0f3
Autor:
Pankit Vachhani, Andrew Perkins, John Mascarenhas, Haifa Kathrin Al-Ali, Jean-Jacques Kiladjian, Sonia Cerquozzi, Jaroslaw Dybko, Regina Garcia Delgado, Jesus Hernández Rivas, Holger Hebart, Zhuying Huang, Cecile Krejsa, Hope Qamoos, Jesse Mcgreivy, Wayne P. Rothbaum, Srdan Verstovsek, Alessandro Vannucchi
Publikováno v:
HemaSphere, Vol 7, p e05521ca (2023)
Externí odkaz:
https://doaj.org/article/261ee9a28228476d9e8db2a327ebc354
Autor:
Michael Gulrajani, Tracy Clevenger, Jean Cheung, Fanny Krantz, Cynthia Nguyen, Miranda Luarca, Cecile Krejsa, Wayne P. Rothbaum, Todd Covey
Publikováno v:
HemaSphere, Vol 7, p e41702a0 (2023)
Externí odkaz:
https://doaj.org/article/259097e869d94146bf92ec05ff2b12da
Autor:
Tracy Clevenger, Jean Cheung, Fanny Krantz, Michael Gulrajani, Cynthia Nguyen, Miranda Luarca, Cecile Krejsa, Wayne P. Rothbaum, Todd Covey
Publikováno v:
HemaSphere, Vol 7, p e281417f (2023)
Externí odkaz:
https://doaj.org/article/3f79b1bcc9b1453983bdc7875797908b
Autor:
Subbaiah Chary Nimmagadda, Paulina Marie Budde, Kaiyan Sun, Todd Covey, Cecile Krejsa, Wayne P. Rothbaum, Nikolas von Bubnoff, Cyrus Khandanpour
Publikováno v:
HemaSphere, Vol 7, p e17451f3 (2023)
Externí odkaz:
https://doaj.org/article/ee8d3fba48f344bfa72e4fcc03cfe2db
Publikováno v:
HemaSphere, Vol 7, p e36170ba (2023)
Externí odkaz:
https://doaj.org/article/662ce407c8f74b1298436e4db6d1fb45
Publikováno v:
HemaSphere, Vol 7, p e722700f (2023)
Externí odkaz:
https://doaj.org/article/a22bf35e59b345cc8df5bf051c4d2ade
Autor:
Shekman, Wong, Cecile, Krejsa, Dana, Lee, Anna, Harris, Emilie, Simard, Xiaohui, Wang, Martine, Allard, Terry, Podoll, Terry, O'Reilly, J Greg, Slatter
Publikováno v:
Clinical Pharmacology in Drug Development. 11:640-653
This single 60-mg dose, 4-period crossover study assessed the effect of food and formulation change on navtemadlin (KRT-232) pharmacokinetics (PK) and macrophage inhibitory cytokine-1 (MIC-1) pharmacodynamics. Healthy subjects (N = 30) were randomize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fb2442e7f2a7b8eeb80df2aa9cffbd8
https://doi.org/10.1002/cpdd.1070
https://doi.org/10.1002/cpdd.1070
Autor:
Bonnie K Harrington, Heather L Gardner, Raquel Izumi, Ahmed Hamdy, Wayne Rothbaum, Kevin R Coombes, Todd Covey, Allard Kaptein, Michael Gulrajani, Bart Van Lith, Cecile Krejsa, Christopher C Coss, Duncan S Russell, Xiaoli Zhang, Bridget K Urie, Cheryl A London, John C Byrd, Amy J Johnson, William C Kisseberth
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159607 (2016)
Acalabrutinib (ACP-196) is a second-generation inhibitor of Bruton agammaglobulinemia tyrosine kinase (BTK) with increased target selectivity and potency compared to ibrutinib. In this study, we evaluated acalabrutinib in spontaneously occurring cani
Externí odkaz:
https://doaj.org/article/885fb92964b3445a99b5a10f0adb8206
Autor:
Zhang, Lu1 (AUTHOR), Poland, Bill1 (AUTHOR), Green, Michelle1 (AUTHOR), Wong, Shekman2,3 (AUTHOR), Slatter, J. Greg2,3 (AUTHOR)
Publikováno v:
Xenobiotica. Jun2022, Vol. 52 Issue 6, p555-566. 12p.